Stay updated on Nivolumab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4. The study details and layout remain unchanged.
    Difference
    0.0%
    Check dated 2026-01-14T02:35:06.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    An administrative change was made: a new Revision: v3.3.3 was added and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer. The study content, eligibility criteria, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T14:24:52.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no substantive changes to study details, eligibility criteria, or page navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T18:24:52.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page no longer displays the government funding lapse notice and NIH Clinical Center operating status guidance. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:59:59.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The core study details and eligibility criteria appear unchanged between the two screenshots; only minor UI formatting differences are visible.
    Difference
    0.3%
    Check dated 2025-11-03T12:36:49.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-05T17:23:46.000Z thumbnail image

Stay in the know with updates to Nivolumab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Hodgkin Lymphoma Clinical Trial page.